G. Armstrong

发表

Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumours.

T. Meyer, D. Talbot, D. Cunningham, 2014, European journal of cancer.

Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour

J. Wason, M. Williams, T. Powles, 2011, British Journal of Cancer.

Is community treatment best? a randomised trial comparing delivery of cancer treatment in the hospital, home and GP surgery

S. Barclay, P. McCrone, A. Prevost, 2013, British Journal of Cancer.

Test of cure and beyond: superiority of thermal ablation over LLETZ in the treatment of high-grade CIN

K. Ragupathy, G. Armstrong, 2022, Archives of Gynecology and Obstetrics.

A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications

P. Corrie, A. M. Moody, D. Parashar, 2012, British Journal of Cancer.

Octreotide suppression test predicts beneficial outcome from antrectomy in a patient with gastric carcinoid tumor.

D. Thompson, D. Thompson, G. Dockray, 1998, Gastroenterology.

A randomised, double blind, placebo-controlled crossover trial of the influence of the HCN channel blocker ivabradine in a healthy volunteer pain model: an enriched population trial.

Michael C. Lee, D. Menon, Daniel Wheeler, 2019, Pain.

Neuroendocrine tumors and CUP

A. Carrato, M. Kudo, R. Salazar, 2012 .